Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging

被引:64
作者
McNerlan, SE
Rea, IM
Alexander, HD
Morris, TCM
机构
[1] Queens Univ Belfast, Dept Geriatr Med, Belfast BT9 7BL, Antrim, North Ireland
[2] Belfast City Hosp, Dept Haematol, Belfast BT9 7AD, Antrim, North Ireland
基金
英国惠康基金;
关键词
aging; natural killer cells; soluble interleukin-2 receptors; lymphocyte subsets;
D O I
10.1023/A:1023283719877
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aging has been shown to be accompanied by various changes in the lymphocyte subset distribution in the elderly. We have investigated more fully, and in a large number of subjects, age-related changes within several subpopulations bearing natural killer (NK) cell-associated surface antigens and changes in several cytokines involved in NK cell expansion. A total of 229 healthy subjects from all decades of life from 20 to 98 years of age was included in this cross-sectional study. A significant increase with age was found in both the absolute counts and the proportions of CD3-CD(16+56)+, CD3+CD(16+56)+, CD57+CD8+, CD57+CD8((low))+, and CD57+CD8- cells, whereas the CD57+CD8((high))+ subset, which may represent the cytolytic T cell population more precisely, showed less change with age. Some evidence is also provided to suggest that these expanded NK cell populations are in an activated state. Soluble IL-2 receptor levels were also found to increase significantly with age and correlated with certain NK cell subsets. Although the functions of some of these subsets remain to be elucidated, their expansion in the elderly may represent a remodeling of the immune system with increasing age, with an increase in non-MHC-restricted cells perhaps compensating for the previously reported decline in T and B cells in the elderly. Alternatively, increased numbers of these cells may be a direct result of cytokine dysregulation or increased antigenic or neoplastic cell challenge.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 39 条
[31]   Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age [J].
Rea, IM ;
Stewart, M ;
Campbell, P ;
Alexander, HD ;
Crockard, AD ;
Morris, TCM .
GERONTOLOGY, 1996, 42 (02) :69-78
[32]  
ROBERTSON MJ, 1990, BLOOD, V76, P2421
[33]  
RUBIN LA, 1986, J IMMUNOL, V137, P3841
[34]   THE SOLUBLE INTERLEUKIN-2 RECEPTOR - BIOLOGY, FUNCTION, AND CLINICAL-APPLICATION [J].
RUBIN, LA ;
NELSON, DL .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (08) :619-627
[35]   CD8(+) T-CELL SUBSETS IN AGING [J].
RUIZ, M ;
ESPARZA, B ;
PEREZ, C ;
BARRANQUERO, M ;
SABINO, E ;
MERINO, F .
IMMUNOLOGICAL INVESTIGATIONS, 1995, 24 (06) :891-895
[36]  
SANSONI P, 1993, BLOOD, V82, P2767
[37]  
TESTI R, 1989, J IMMUNOL, V142, P1854
[38]   Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15 [J].
TreiberHeld, S ;
Stewart, DM ;
Barraclough, HA ;
Kurman, CC ;
Nelson, DL .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 80 (01) :67-75
[39]  
WANG ECY, 1993, CLIN EXP IMMUNOL, V94, P297